封面
市場調查報告書
商品編碼
1448070

阿什瓦甘達市場 - 2023-2030

Ashwagandha Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年,全球南非醉茄市場規模達8.6412億美元,預計2030年將達到13,566.2億美元,2023-2030年預測期間CAGR為5.8%。

消費者高度採用南非醉茄及其產品,因為南非醉茄被認為是自古以來的天然阿育吠陀草藥。它被廣泛用作治療壓力和焦慮的適應原藥物,它也有助於治療各種疾病,如癌症、糖尿病等。因此,這些因素可能有助於推動全球南非醉茄市場的發展。

此外,為了滿足對天然補充劑產品不斷成長的需求,製造公司正在積極創造和推出創新產品來滿足消費者的需求。例如,2023 年 4 月,總部位於南加州的補充劑公司 Youtheory 更新了其產品組合。 Ashwagandha + GABA 含有 100 毫克藥物 GABA。它被證明可以克服壓力並促進放鬆,而不促進困倦。

以運動和營養為主的南非醉茄補充劑和亞太地區佔據了全球南非醉茄市場的最大佔有率。 Ashwagandha 被認為是自古以來的阿育吠陀藥物。政府和製造商也提供了一些擴大市場成長的措施。

動力學

對 Ashwagandha 補充劑的需求不斷增加

消費者正在高度尋求合成藥物的替代來源,這可以極大地幫助增加對南非醉茄作為天然補充劑的需求,因為它們的適應原特性有助於控制壓力和焦慮。因此,對南非醉茄補充劑的需求不斷成長正在推動全球南非醉茄市場的成長。

此外,對基於南非醉茄的補充劑的需求增加有助於為製造商創造創新產品的機會。例如,2021年2月,LupinLife公司推出了一款男性阿育吠陀能量補充劑Be One。它是一種 100% 奧吠陀健康和保健補充劑,含有南非醉茄等天然成分。

對阿育吠陀藥物的需求不斷增加

由於對阿育吠陀藥物的需求不斷增加,預計南非醉茄萃取物的市場將顯著成長。這些萃取物是一種天然藥物形式,傳統上用於阿育吠陀治療,以解決各種健康問題,包括但不限於痤瘡、焦慮和心血管疾病。

此外,製造公司正在推出南非醉茄的阿育吠陀產品,以擴大其市場規模。例如,2024 年 1 月,Hi-Tech Pharmaceuticals 推出了 Ashwagandha 品牌的 AshwaPure,它是所有主要根中濃度最高的,有助於減輕焦慮、降低血糖水平、力量和耐力。

過敏反應

Ashwagandha 具有許多藥用特性,但需要注意的是,有些人可能會對它過敏。過敏反應多種多樣,從瘙癢和皮疹等輕微症狀到腫脹和呼吸困難等更嚴重的反應。這可能會限制消費者數量並影響市場的成長。

目錄

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 按類型分類的片段
  • 按產品類型分類的片段
  • 按表格列出的片段
  • 按功能分類的片段
  • 按配銷通路分類的片段
  • 按應用程式片段
  • 按地區分類的片段

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 對 Ashwagandha 補充劑的需求不斷增加
      • 對阿育吠陀藥物的需求不斷增加
    • 限制
      • 過敏反應
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:按類型

  • KSM-66
  • 感應器
  • 水醇阿什瓦甘達
  • 粗南非醉茄

第 8 章:依產品類型

  • 南非醉茄根
  • 阿什瓦甘達葉
  • 根混合產品
  • 醉茄內酯含量(1%-10%)
  • 其他

第 9 章:按形式

  • 粉末
  • 膠囊
  • 藥丸
  • 液體

第 10 章:按功能

  • 提高耐力
  • 提高免疫力
  • 整體健康
  • 減少焦慮和壓力
  • 大腦健康
  • 肌肉力量
  • 其他

第 11 章:按配銷通路

  • 大型超市/超市
  • 專賣店
  • 藥局和藥房
  • 便利商店
  • 網路零售通路
  • 其他

第 12 章:按應用

  • 食品和飲料
  • 製藥
  • 運動營養
  • 其他

第 13 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第14章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 15 章:公司簡介

  • Baldwa group
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Sami-Sabinsa Group
  • Dabur India Ltd
  • Himalaya Wellness Company.
  • Swanson
  • Patanjali Ayurved Limited
  • Kerry Group plc
  • KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED
  • Bioprex Labs
  • Medikonda Nutrients.

第 16 章:附錄

簡介目錄
Product Code: FB8146

Overview

Global Ashwagandha Market reached US$ 864.12 million in 2022 and is expected to reach US$ 1356.62 billion by 2030, growing with a CAGR of 5.8% during the forecast period 2023-2030.

Consumers are highly adopting the ashwagandha and their products, as the ashwagandha is considered a natural ayurvedic herb from ancient times. It is highly used as adaptogen medicine for stress and anxiety, it also helps to cure various diseases such as cancer, diabetes, and others. Hence, such factors can contribute to driving the global ashwagandha market.

Furthermore, in response to the growing demand for natural supplement products, manufacturing companies are actively creating and introducing innovative products to meet consumer needs. For instance, in April 2023, Southern California-based supplement company- Youtheory updated its portfolios. Ashwagandha + GABA has 100mg of pharma GABA. It is shown to overcome stress and encourage relaxation, without promoting sleepiness.

The sports and nutrition-based ashwagandha supplements and Asia-Pacific region accounted for the largest share of the global ashwagandha market. Ashwagandha is believed to be the Ayurvedic medicine from ancient times. The government and manufacturers also provide some initiatives to expand the market growth.

Dynamics

Increasing Demand for Ashwagandha Supplements

Consumers are highly seeking alternative sources of synthetic drugs, which can significantly help in increasing the demand for ashwagandha as a natural supplement, as their adaptogenic properties help in managing stress and anxiety. Hence, the increasing demand for ashwagandha supplements is propelling the growth of the global ashwagandha market.

Furthermore, the increased demand for ashwagandha-based supplements can help to create opportunities for manufacturers to create innovative products. For instance, in February 2021, LupinLife company launched an ayurvedic energy supplement for men, Be One. It is a 100% aurvedic health and wellness supplement, which contains natural ingredients including ashwagandha.

Increasing Demand for Ayurvedic Medicines

The market for ashwagandha extracts is predicted to grow significantly due to the increasing demand for ayurvedic medicines. These extracts are a natural form of medicine that have been traditionally used in ayurvedic treatments to address various health conditions, including but not limited to acne, anxiety, and cardiovascular diseases.

In addition, the manufacturing companies are launching ayurvedic products of ashwagandha to expand their market sizes. For instance, in January 2024, Hi-Tech Pharmaceuticals launched AshwaPure under the ashwagandha brand, it has the highest concentration of all major roots, and it helps in reducing anxiety, and lowering blood sugar levels, strength, and stamina.

Allergic Reactions

Ashwagandha has many medicinal properties, but it's important to note that some people may be allergic to it. Allergic reactions can vary from mild symptoms like itching and rash to more severe reactions such as swelling and difficulty breathing. This can potentially limit the number of consumers and impact the growth of the market.

Segment Analysis

The global ashwagandha market is segmented based on type, product type, form, function, distribution channel, application, and region.

Increasing Demand for Natural Sport Nutrition Products

The sports nutrition category holds the largest portion of the global ashwagandha market. The sports supplement industry is increasingly incorporating ashwagandha into various products due to its potential to regulate cortisol levels. This herb can help to assist in managing the stress response associated with intense exercise. Additionally, ashwagandha is gaining attention for its potential contributions to strength and muscle mass improvements, along with a positive impact on cardiovascular health.

Furthermore, as the demand for natural sports supplements is increasing among consumers, manufacturing companies are launching innovative products in their portfolios. For instance, in September 2020, India's sports nutrition brand MuscleBlaze combined the merits of immune and sports nutrition into one product, it launched an ashwagandha-enriched whey protein powder Biozyme Immunity Whey.

Geographical Penetration

Government Initiatives and Product Launches

The Asia-Pacific region shows the dominance in global ashwagandha market, as ashwagandha has been widely used as a medicinal and ayurvedic plant from ancient times in India, consumers in this region are highly adopting these ashwagandha and their based products as it offers various potential health benefits. Hence such cultural inclination toward herbal supplements can help in driving the ashwagandha market.

Furthermore, the regional government is developing new initiatives to meet increasing demand. For instance, in October 2022, the government of India launched the cultivation of the medicinal plant Ashwagandha on a 200-acre plantation in the Dindigul district, India. This project aims to make Dindigul a hub for medicinal plants.

Additionally, the manufacturers of this region are actively supporting the growing demand by developing innovative products. For instance, in December 2021, Wellness Brand Nidra Nutrition, a part of Supercluster Pi launched a product line of stress relief gummies containing 175 mg of Ashwagandha in India.

Competitive Landscape

The major global players in the market include Baldwa Group, Sami-Sabinsa Group, Dabur India Ltd, Himalaya Wellness Company., Swanson, Patanjali Ayurved Limited, Kerry Group plc, KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED, Bioprex Labs, and Medikonda Nutrients.

COVID-19 Impact Analysis

The pandemic had brought a significantly positive impact on the global ashwagandha market. Due COVID-19 virus, the pandemic, and the lockdown situation and restrictions have caused stress and anxiety among consumers the coronavirus also affected the immune system of the patients. Ashwagandha helps in enhancing the immune system, this has increased the demand for the ashwagandha market.

Additionally, during COVID-19 consumers widely started adopting natural and ayurvedic products which has raised the demand for the usage of ashwagandha for various herbal and medicinal products to treat anxiety and other issues, this has raised the sales of ashwagandha and ashwagandha-based products.

By Type

  • KSM-66
  • Sensoril
  • Hydro-Alcoholic Ashwagandha
  • Crude Ashwagandha

By Product Type

  • Ashwagandha Root
  • Ashwagandha Leaf
  • Root Mix Products
  • Withanolides Content (1% -10%)
  • Others

By Form

  • Powder
  • Capsule
  • Pills
  • Liquid

By Function

  • Improve Stamina
  • Improve Immunity
  • Overall Wellbeing
  • Reduces Anxiety and Stress
  • Brain Health
  • Muscle Strength
  • Others

By Distribution Channel

  • Hypermarket/Supermarket
  • Specialty Stores
  • Drug Stores & Pharmacies
  • Convenience Stores
  • Online Retail Channels
  • Others

By Application

  • Food & Beverages
  • Sports & Nutrition
  • Pharmaceutical
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In April 2022, Kerry Group PLC, the taste and nutrition company, announced it had completed the acquisition of U.S.-based Natreon, Inc., a leading supplier of branded Ayurvedic botanical ingredients. The acquisition significantly expands Kerry's leadership position and ProActive Health's portfolio of science-backed branded ingredients which includes ashwagandha, and others furthering the company's technology growth.
  • In December 2021, Glanbia Nutritionals PLC partnered with Ixoreal Biomed Inc. to optimize its KSM-66 Ashwagandha, highly concentrated root extract with NutraShield Technology, to provide functional and application dosage improvements.
  • In September 2022, Nutriventia launched sustained-release Prolanza ashwagandha, the pharmacokinetic study concluded that Prolanza had a higher rate of bioavailability and absorption, and a longer shelf-life than another well-known ingredient.

Why Purchase the Report?

  • To visualize the global ashwagandha market segmentation based on type, product type, form, function, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ashwagandha market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global ashwagandha market report would provide approximately 86 tables, 94 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Product Type
  • 3.3.Snippet by Form
  • 3.4.Snippet by Function
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Application
  • 3.7.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Demand for Ashwagandha Supplements
      • 4.1.1.2.Increasing Demand for Ayurvedic Medicines
    • 4.1.2.Restraints
      • 4.1.2.1.Allergic Reactions
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.KSM-66*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Sensoril
  • 7.4.Hydro-Alcoholic Ashwagandha
  • 7.5.Crude Ashwagandha

8.By Product Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2.Market Attractiveness Index, By Product Type
  • 8.2.Ashwagandha Root*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Ashwagandha Leaf
  • 8.4.Root Mix Products
  • 8.5.Withanolides Content (1% -10%)
  • 8.6.Others

9.By Form

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.1.2.Market Attractiveness Index, By Form
  • 9.2.Powder*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Capsule
  • 9.4.Pills
  • 9.5.Liquid

10.By Function

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.1.2.Market Attractiveness Index, By Function
  • 10.2.Improve Stamina*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Improve Immunity
  • 10.4.Overall Wellbeing
  • 10.5.Reduces Anxiety and Stress
  • 10.6.Brain Health
  • 10.7.Muscle Strength
  • 10.8.Others

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Hypermarket/Supermarket*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Specialty Stores
  • 11.4.Drug Stores & Pharmacies
  • 11.5.Convenience Stores
  • 11.6.Online Retail Channels
  • 11.7.Others

12.By Application

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2.Market Attractiveness Index, By Application
  • 12.2.Food & Beverages*
    • 12.2.1.Introduction
    • 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3.Pharmaceutical
  • 12.4.Sports Nutrition
  • 12.5.Others

13.By Region

  • 13.1.Introduction
    • 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2.Market Attractiveness Index, By Region
  • 13.2.North America
    • 13.2.1.Introduction
    • 13.2.2.Key Region-Specific Dynamics
    • 13.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.9.1.U.S.
      • 13.2.9.2.Canada
      • 13.2.9.3.Mexico
  • 13.3.Europe
    • 13.3.1.Introduction
    • 13.3.2.Key Region-Specific Dynamics
    • 13.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.9.1.Germany
      • 13.3.9.2.UK
      • 13.3.9.3.France
      • 13.3.9.4.Italy
      • 13.3.9.5.Russia
      • 13.3.9.6.Rest of Europe
  • 13.4.South America
    • 13.4.1.Introduction
    • 13.4.2.Key Region-Specific Dynamics
    • 13.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.9.1.Brazil
      • 13.4.9.2.Argentina
      • 13.4.9.3.Rest of South America
  • 13.5.Asia-Pacific
    • 13.5.1.Introduction
    • 13.5.2.Key Region-Specific Dynamics
    • 13.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.9.1.China
      • 13.5.9.2.India
      • 13.5.9.3.Japan
      • 13.5.9.4.Australia
      • 13.5.9.5.Rest of Asia-Pacific
  • 13.6.Middle East and Africa
    • 13.6.1.Introduction
    • 13.6.2.Key Region-Specific Dynamics
    • 13.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14.Competitive Landscape

  • 14.1.Competitive Scenario
  • 14.2.Market Positioning/Share Analysis
  • 14.3.Mergers and Acquisitions Analysis

15.Company Profiles

  • 15.1.Baldwa group*
    • 15.1.1.Company Overview
    • 15.1.2.Product Portfolio and Description
    • 15.1.3.Financial Overview
    • 15.1.4.Key Developments
  • 15.2.Sami-Sabinsa Group
  • 15.3.Dabur India Ltd
  • 15.4.Himalaya Wellness Company.
  • 15.5.Swanson
  • 15.6.Patanjali Ayurved Limited
  • 15.7.Kerry Group plc
  • 15.8.KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED
  • 15.9.Bioprex Labs
  • 15.10.Medikonda Nutrients.

LIST NOT EXHAUSTIVE

16.Appendix

  • 16.1.About Us and Services
  • 16.2.Contact Us